These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9193008)

  • 21. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial.
    Spaulding C; Charbonnier B; Cohen-Solal A; Juillière Y; Kromer EP; Benhamda K; Cador R; Weber S
    Circulation; 1998 Aug; 98(8):757-65. PubMed ID: 9727545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction].
    Kardiologiia; 2008; 48(11):64-8. PubMed ID: 19076083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction.
    Schulman SP; Weiss JL; Becker LC; Guerci AD; Shapiro EP; Chandra NC; Siu C; Flaherty JT; Coombs V; Taube JC
    Am J Cardiol; 1995 Oct; 76(11):764-70. PubMed ID: 7572651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure.
    Harjai KJ; Solis S; Prasad A; Loupe J
    Int J Cardiol; 2003 Apr; 88(2-3):207-14. PubMed ID: 12714200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
    Lam PH; Dooley DJ; Fonarow GC; Butler J; Bhatt DL; Filippatos GS; Deedwania P; Forman DE; White M; Fletcher RD; Arundel C; Blackman MR; Adamopoulos C; Kanonidis IE; Aban IB; Patel K; Aronow WS; Allman RM; Anker SD; Pitt B; Ahmed A
    Eur J Heart Fail; 2018 Feb; 20(2):359-369. PubMed ID: 28980368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic interaction of aspirin with enalapril.
    Guazzi M
    Circulation; 1999 Dec; 100(25):e141-2. PubMed ID: 10604908
    [No Abstract]   [Full Text] [Related]  

  • 28. [High doses of aspirin reduce natriuresis in hypertensive patients treated with enalapril].
    Di Gennaro FP; Cingolani OH; Abbate AF; Toblli JE; Vilches A
    Medicina (B Aires); 2004; 64(4):301-5. PubMed ID: 15338971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII].
    Dessì-Fulgheri P; Paci MV; Rappelli A
    Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction.
    Guazzi MD; Campodonico J; Celeste F; Guazzi M; Santambrogio G; Rossi M; Trabattoni D; Alimento M
    Clin Pharmacol Ther; 1998 Jan; 63(1):79-86. PubMed ID: 9465844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.
    Teo KK; Yusuf S; Pfeffer M; Torp-Pedersen C; Kober L; Hall A; Pogue J; Latini R; Collins R;
    Lancet; 2002 Oct; 360(9339):1037-43. PubMed ID: 12383982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group.
    Wu N; Fan Z
    Chin Med J (Engl); 1997 Aug; 110(8):602-6. PubMed ID: 9594263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitor therapy affects myocardial fatty acid metabolism after acute myocardial infarction.
    Fukuzawa S; Ozawa S; Inagaki M; Sugioka J; Daimon M; Kushida S
    J Nucl Cardiol; 2000; 7(1):23-8. PubMed ID: 10698231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents].
    Savenkov MP; Ivanov SN; Brodskaia SA
    Ter Arkh; 2001; 73(9):27-31. PubMed ID: 11642076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II and trials of cardiovascular outcomes.
    Sleight P
    Am J Cardiol; 2002 Jan; 89(2A):11A-16A; discussion 16A-17A. PubMed ID: 11835905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Guazzi M; Melzi G; Agostoni P
    Am J Cardiol; 1997 Dec; 80(12):1572-6. PubMed ID: 9416938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons from recent randomized controlled trials for the management of congestive heart failure.
    Riegger GA
    Am J Cardiol; 1993 Jun; 71(17):38E-40E. PubMed ID: 8328366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation.
    Borchert T; Hess A; Lukačević M; Ross TL; Bengel FM; Thackeray JT
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(7):1757-1768. PubMed ID: 32125488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.